Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
PKI
$148.52
Perkinelmer
$.39
.26%
PKI
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus: $3.60
Revenue: $918.01 Mil
Tuesday
Feb 2
4:05 PM ET
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Latest EPS
Wednesday, October 28, 2020
PerkinElmer Announces Financial Results for the Third Quarter of 2020
What do you expect when PKI reports earnings?
Beat
Meet
Miss
Where is PKI's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$153.46
$151.47
$150.00
$148.01
Support
$146.54
$144.55
$143.08
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Their dedicated team of whole employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets. Their innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around them.
Peers
Illumina
Agilent Technologies
Translate Bio
Coherent
Harvard Bioscience
Bio-Rad Laboratories
Expectations
›
Perkinelmer